Journal of neurosurgery · 2013 · 20 citations · 29 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular OncologySignal TransductionApoptotic Signal TransductionCancer Cell SignalingGlioblastomaOncogenic Signaling PathwaysSignal Transduction In CancerTumor Suppressor GenesBcl-2 Protein ExpressionCancer Signaling PathwaysCell Growth RegulationCell Proliferation IndicesGlioblastoma MigrationProtein Expression LevelsTumor Suppressor PathwaysWestern Blot Analysis
OBJECT: Signal transducer and activator of transcription 1 (STAT1) is thought to be a tumor suppressor protein. The authors investigated the expression and role of STAT1 in glioblastoma. METHODS: Immunohistochemistry was used to detect the expression of STAT1 in glioblastoma and normal brain tissues. Reverse transcription-polymerase chain reaction and Western blot analysis were used to detect mRNA and protein expression levels of STAT1. Cell growth, proliferation, migration, apoptosis, and the expression of related genes and proteins (Bcl-2, Bax, cleaved caspase-3, caspase-9, p21, and proliferating cell nuclear antigen) were examined in vitro via cell counting kit-8, wound-healing, flow cytometry, Rhodamine B, TUNEL, and Western blot assays. RESULTS: Human glioblastoma had decreased expression of STAT1 proteins. Transfection of the U87MG cells with STAT1 plasmid in vitro demonstrated significant inhibition of cell growth and an increase in apoptotic cell death compared with cells transfected with vector or mock plasmids. These effects were associated with the upregulation of cleaved caspase-3, Bax, and p21 and the downregulation of Bcl-2 expression. CONCLUSIONS: The results of this study suggest that increased expression of STAT1 by transfection with STAT1 plasmid synergistically inhibits human U87MG glioblastoma cell growth in vitro.
29
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Joan E. Durbin, Renée Hackenmiller, M. Celeste Simon et al. · Cell · 1996 · 1.6K citations · Full text
Life Sciences, Genetics, Immunology +17